Search

Glenn P Vonk

from Ijamsville, MD
Age ~68
Get Report
Also known as:
Glenn T Vonk, Glenn P Yonk
Related to:
Carolyn Dundon Torres, 90Eric Christian Buckey Erichsen, 31John Mccann, 62Douglas J Mccann, 39Christian Erichsen, 82Jason Erichsen, 34Erichsen Buckey, 42
Connected to:
Joyce D Vonk, 60Kelsey T Vonk, 29Martin J Vonk, 72Ronald J Vonk, 76Ryan B Vonk, 40Sarah E Vonk, 39Pamela J Vonkahle, 65Noel E Vonkauffmann, 52Brandy M Vonkelsheimer, 50Erik E Vonkiel, 68

Glenn Vonk Phones & Addresses

  • Ijamsville, MD
  • 2717 Piney Grove Wilbon Rd, Fuquay Varina, NC 27526
  • Detroit, MI
  • Hialeah, FL

Work

Company: National council of entrepreneurial technology transfer Apr 2016 Position: Director of business development and alliances

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Wayne State University 1978 to 1983 Specialities: Chemistry

Skills

Program Management • Cell • Bioinformatics • Infectious Diseases • Assay Development • Medical Diagnostics • Biochemistry • Biotechnology • Lifesciences • Analytical Chemistry • Biopharmaceuticals • Cancer • Cell Culture • Chromatography • Chemistry • Biomedical Engineering • Cell Biology • Clinical Trials • Commercialization • Clinical Development • Business Development

Industries

Biotechnology

Resumes

Resumes

Glenn Vonk Photo 1

Director Of Business Development And Alliances

View page
Location:
2717 Piney Grove Rd, Fuquay Varina, NC
Industry:
Biotechnology
Work:
National Council of Entrepreneurial Technology Transfer
Director of Business Development and Alliances
Bd 2012 - 2013
Director Advanced Technology
Bd Aug 2008 - Dec 2012
Director, Bioventure Centre
Bd Technologies 2005 - 2008
Technology Manager
Education:
Wayne State University 1978 - 1983
Doctorates, Doctor of Philosophy, Chemistry
Skills:
Program Management
Cell
Bioinformatics
Infectious Diseases
Assay Development
Medical Diagnostics
Biochemistry
Biotechnology
Lifesciences
Analytical Chemistry
Biopharmaceuticals
Cancer
Cell Culture
Chromatography
Chemistry
Biomedical Engineering
Cell Biology
Clinical Trials
Commercialization
Clinical Development
Business Development

Publications

Us Patents

Intra-Dermal Delivery Of Biologically Active Agents

View page
US Patent:
20050163711, Jul 28, 2005
Filed:
Jun 14, 2004
Appl. No.:
10/867908
Inventors:
Colleen Nycz - Raleigh NC, US
Glenn Vonk - Fuquay Varina NC, US
John Brittingham - Wake Forest NC, US
Ronald Pettis - Cary NC, US
Alfred Harvey - Durham NC, US
Robert Campbell - Bahama NC, US
John Mikszta - Durham NC, US
Diane Sutter - Cary NC, US
International Classification:
A61K049/00
US Classification:
424009100
Abstract:
The present invention relates to methods and devices for delivering one or more biologically active agents, particularly a diagnostic agent to the intradermal compartment of a subject's skin. The present invention provides an improved method of delivery of biologically active agents in that it provides among other benefits, rapid uptake into the local lymphatics, improved targeting to a particular tissue, improved bioavailability, improved tissue bioavailability, improved tissue specific kinetics, improved deposition of a pre-selected volume of the agent to be administered, and rapid biological and pharmacodynamics and biological and pharmacokinetics. This invention provides methods for rapid transport of agents through lymphatic vasculature accessed by intradermal delivery of the agent. Methods of the invention are particularly useful for delivery of diagnostic agents.

Methods For Intradermal Delivery Of Therapeutics Agents

View page
US Patent:
20050180952, Aug 18, 2005
Filed:
Jun 14, 2004
Appl. No.:
10/868482
Inventors:
Ronald Pettis - Cary NC, US
Alfred Harvey - Durham NC, US
Robert Campbell - Bahama NC, US
John Mikszta - Durham NC, US
John Brittingham - Wake Forest NC, US
Glenn Vonk - Fuquay Varina NC, US
Colleen Nycz - Raleigh NC, US
International Classification:
A61K038/20
A61K038/21
A61K039/395
A61K045/00
US Classification:
424085200, 424085400, 424130100, 514002000, 604500000
Abstract:
The present invention relates to methods and devices for delivering one or more biologically active agents, particularly therapeutic agents, to the intradermal compartment of a subject's skin. The present invention provides an improved method of delivery of biologically active agents, such as therapeutic agents, through lymphatic vasculature accessed by intradermal delivery. Therapeutic agents to be delivered in accordance with the present invention include, but are not limited to, antineoplastic agents, chemotherapeutic agents, antibodies, antibiotics, anti-angiogenesis agents, anti-inflammatory agents, and immunotherapeutic agents. Therapeutic agents delivered in accordance with the present invention have improved bioavailability, including improved systemic distribution and improved delivery to particular tissues. Therapeutic agents delivered in accordance with the methods of the invention have an improved clinical utility and therapeutic efficacy relative to other drug delivery methods, including intraperitoneal, intramuscular and subcutaneous delivery. The methods of the present invention provide benefits and improvements over conventional drug delivery methods including dose sparing, increased drug efficacy, reduced side effects, reduced metastatic potential and prolonged survival.

Methods And Kits For The Diagnosis Of Influenza

View page
US Patent:
20190339272, Nov 7, 2019
Filed:
Apr 15, 2019
Appl. No.:
16/384020
Inventors:
- Franklin Lakes NJ, US
Kevin G. Dolan - Holly Springs NC, US
Eric Fallows - Apex NC, US
Randal A. Hoke - Cary NC, US
Ross Jacobson - Hillsborough NC, US
J. Bruce Pitner - Durham NC, US
Glenn P. Vonk - Fuquay Varina NC, US
Rajashaker Kache - Cary NC, US
Upma Gulati - Cary NC, US
International Classification:
G01N 33/569
C07H 15/203
Abstract:
Some embodiments provided herein relate to combined assays. In some embodiments, an assay for identifying influenza type A or influenza type B is combined with an assay for determining the sensitivity of an influenza neuraminidase to an antiviral drug.

System For Sorting And Dispensing Oral Medications

View page
US Patent:
20160075460, Mar 17, 2016
Filed:
Sep 11, 2015
Appl. No.:
14/852215
Inventors:
- Franklin Lakes NJ, US
Theresa Forshey - Durham NC, US
Glenn Vonk - Fuquay-Varina NC, US
Dylan Wilson - Pittsboro NC, US
Adam Martin - Holly Springs NC, US
Sundeep Kankanala - Chapel Hill NC, US
International Classification:
B65B 57/20
Abstract:
A system for assisting patients in sorting and dispensing medication supplies comprises a storage tray having a number of storage compartments, and a communication system to identify a medication to be provided from a pill bottle and, based upon the identification and a known regime, automatically identify which compartments of the storage tray are to be filled with the identified medication from the pill bottle and perform the filling of the storage tray. In doing so, a patient can simply open and present any number of pill bottles to the system, and then allow the system to arrange the medication in the storage tray according to the known regimen. The regimen and regimen updates are communicated to the system by means of a wired or wireless transmission to the system from a remote location (e.g. pharmacy or doctor's office), by direct user input, or by reading such information from a barcode or similar information carrier affixed to the pill bottles.

Methods And Kits For The Diagnosis Of Influenza

View page
US Patent:
20160041167, Feb 11, 2016
Filed:
Apr 1, 2014
Appl. No.:
14/781008
Inventors:
- Franklin Lakes NJ, US
Kevin G. Dolan - Holly Springs NC, US
Eric Fallows - Apex NC, US
Randall A. Hoke - Cary NC, US
Ross Jacobson - Hillsborough NC, US
J. Bruce Pinter - Durham NC, US
Glenn P. Vonk - Fuquay Varina NC, US
Rajashaker Kache - Cary NC, US
Upma Gulati - Franklin Lakes NC, US
Herman Himel - Cary NC, US
International Classification:
G01N 33/569
C07H 15/203
Abstract:
Some embodiments provided herein relate to combined assays. In some embodiments, an assay for identifying influenza type A or influenza type B is combined with an assay for determining the sensitivity of an influenza neuraminidase to an antiviral drug.

Methods For Preparing Dry Formulations Of Glucose Binding Protein

View page
US Patent:
20150056634, Feb 26, 2015
Filed:
Mar 28, 2013
Appl. No.:
14/388957
Inventors:
- Franklin Lakes NJ, US
Javier Alarcon - Durham NC, US
Glenn P. Vonk - Fuquay-Varina NC, US
Melody M.H. Kuroda - Durham NC, US
Mark Foster Sistare - Apex NC, US
Brandi Marie Ford - Apex NC, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G01N 33/66
C07K 14/245
US Classification:
435 79, 530350, 436501, 435 71
Abstract:
Methods and compositions for preparing dry formulations of Glucose Binding Proteins (GBPs) are disclosed. The GBPs may be stored as a dry formulation without significant loss of activity. After reconstitution, the GBPs may be used to determine the glucose concentration of a sample.

Biosensors For Measuring Analytes In The Interstitial Fluid

View page
US Patent:
20080275318, Nov 6, 2008
Filed:
Apr 21, 2008
Appl. No.:
12/107033
Inventors:
Alexander LASTOVICH - Raleigh NC, US
Jacob Hartsell - Raleigh NC, US
Javier Alarcon - Durham NC, US
Glenn Vonk - Fuquay-Varina NC, US
Bruce Clyde Roberts - Hillsborough NC, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
A61B 5/1459
A61B 5/145
US Classification:
600316, 600365
Abstract:
The invention relates to methods and devices for measuring blood glucose levels in a subject, where the methods and devices are designed for exposing a sensing mechanism to interstitial fluid in the subject.

Multianalyte Sensor

View page
US Patent:
20060078908, Apr 13, 2006
Filed:
Jun 7, 2005
Appl. No.:
11/145944
Inventors:
James Pitner - Durham NC, US
Glenn Vonk - Fuquay-Varina NC, US
International Classification:
C12Q 1/68
G01N 33/53
C12Q 1/54
C12M 1/34
US Classification:
435006000, 435007100, 435014000, 435287100
Abstract:
The invention relates to devices for continuously measuring the concentrations of more than one target analyte. Specifically, the devices comprise a plurality of analyte binding domains, with each domain being capable of specifically and reversibly binding to at least one of the target analytes. The devices further comprise a membrane surrounding these binding domains that is permeable to the target analytes. The devices convey binding information to a detector. The invention also relates to methods of using the devices, including monitoring chronic disease states in an individual.
Control profile
Glenn P Vonk from Ijamsville, MD, age ~68 Get Report